RobertLindsayMD

PubMed

• Administration of teriparatide for four years cyclically compared to two years daily in treatment naïve and alendronate treated women.
  Cosman, F.,Nieves, J. W.,Roimisher, C.,Neubort, S.,McMahon, D. J.,Dempster, D. W.,Lindsay, R.> ;Bone. 2018 Oct 26
• Teriparatide for osteoporosis: importance of the full course.
  Lindsay R, Krege JH, Marin F, Jin L, Stepan JJ> ;Osteoporos Int. 2016-08-01
• 25 citations
  Effect of Teriparatide on Bone Formation in the Human Femoral Neck.
  Felicia Cosman, David W. Dempster, Jeri W. Nieves, Hua Zhou, Marsha Zion, Catherine Roimisher, Yvonne Houle, Robert Lindsay, Mathias P.G. Bostrom> ;The Journal of Clinical Endocrinology and Metabolism. 2016 Feb 22
• 41 citations
  Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study
  David W. Dempster, Hua Zhou, Robert R. Recker, Jacques P. Brown, Christopher Recknor, E. Michael Lewiecki, Paul D. Miller, Sudhaker D Rao, David L. Kendler, Robert Lin...> ;The Journal of Clinical Endocrinology and Metabolism. 2016 Feb 10
• 31 citations
  The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network Trials
  Jochen G. Raimann, Christopher T. Chan, John T. Daugirdas, Tom Depner, Frank A. Gotch, Tom Greene, George A. Kaysen, Alan S. Kliger, Peter Kotanko, Brett Larive, Rober...> ;Blood Purification. 2016 Jan 21
• 74 citations
  Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial
  Michael V. Rocco, John T. Daugirdas, Tom Greene, Robert S. Lockridge, Christopher T. Chan, Andreas Pierratos, Robert M. Lindsay, Brett Larive, Glenn M. Chertow, Gerald...> ;American Journal of Kidney Diseases. 2015 Sep 1
• Erratum to: Clinician's guide to prevention and treatment of osteoporosis.
  Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R> ;Osteoporos Int. 2015-07-01
• End-stage renal disease and survival in people with diabetes: a national database linkage study.
  Bell S, Fletcher EH, Brady I, Looker HC, Levin D, Joss N, Traynor JP, Metcalfe W, Conway B, Livingstone S, Leese G, Philip S, Wild S, Halbesma N, Sattar N, Lindsay RS,...> ;QJM. 2015-02-01
• Clinician's Guide to Prevention and Treatment of Osteoporosis.
  Cosman, F.,de Beur, S. J.,LeBoff, M. S.,Lewiecki, E. M.,Tanner, B.,Randall, S.,Lindsay, R.> ;Osteoporos Int. 2014 Sep 04
• Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme.
  Looker HC, Nyangoma SO, Cromie DT, Olson JA, Leese GP, Black MW, Doig J, Lee N, Lindsay RS, McKnight JA, Morris AD, Pearson DWM, Philip S, Wild SH, Colhoun HM> ;Br J Ophthalmol. 2014-06-01
• The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group.
  Siris, E. S.,Adler, R.,Bilezikian, J.,Bolognese, M.,Dawson-Hughes, B.,Favus, M. J.,Harris, S. T.,Jan de Beur, S. M.,Khosla, S.,Lane, N. E.,Lindsay, R.,Nana, A. D.,Orwo...> ;Osteoporos Int. 2014 Mar 01
• Risk stratification for diabetic eye screening. Reply to Stratton I. M. and Aldington S. J. [letter].
  Looker HC, Nyangoma SO, Cromie DT, Olson JA, Leese GP, Philip S, Black MW, Doig J, Lee N, Briggs A, Hothersall EJ, Morris AD, Lindsay RS, McKnight JA, Pearson DWM, Sat...> ;Diabetologia. 2014-01-01
• Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme.
  Looker HC, Nyangoma SO, Cromie DT, Olson JA, Leese GP, Philip S, Black MW, Doig J, Lee N, Briggs A, Hothersall EJ, Morris AD, Lindsay RS, McKnight JA, Pearson DWM, Sat...> ;Diabetologia. 2013-08-01
• 14 citations
  Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy
  Robert Lindsay, Nelson B. Watts, J. L. Lange, Pierre D. Delmas, Stuart L. Silverman> ;Osteoporosis International. 2013 Apr 24
• Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW).
  Ioannidis G, Flahive J, Pickard L, Papaioannou A, Chapurlat RD, Saag KG, Silverman S, Anderson FA, Gehlbach SH, Hooven FH, Boonen S, Compston JE, Cooper C, Díez-Perez ...> ;Osteoporos Int. 2013-01-01
• Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs.
  Colhoun HM, Livingstone SJ, Looker HC, Morris AD, Wild SH, Lindsay RS, Reed C, Donnan PT, Guthrie B, Leese GP, McKnight J, Pearson DWM, Pearson E, Petrie JR, Philip S,...> ;Diabetologia. 2012-11-01
• Skeletal effects of vitamin D supplementation in postmenopausal black women.
  Nieves, J. W., Cosman, F., Grubert, E., Ambrose, B., Ralston, S. H., Lindsay, R.> ;Calcif Tissue Int. 2012 Nov
• Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland.
  Looker HC, Nyangoma SO, Cromie D, Olson JA, Leese GP, Black M, Doig J, Lee N, Lindsay RS, McKnight JA, Morris AD, Philip S, Sattar N, Wild SH, Colhoun HM> ;Diabetologia. 2012-09-01
• The effect of frequent hemodialysis on nutrition and body composition: frequent Hemodialysis Network Trial.
  Kaysen GA, Greene T, Larive B, Mehta RL, Lindsay RM, Depner TA, Hall YN, Daugirdas JT, Chertow GM> ;Kidney Int.. 2012-07-01
• 71 citations
  Effects of Six versus Three Times per Week Hemodialysis on Physical Performance, Health, and Functioning: Frequent Hemodialysis Network (FHN) Randomized Trials
  Yoshio N. Hall, Brett Larive, Patricia Painter, George A. Kaysen, Robert M. Lindsay, Allen R. Nissenson, Mark Unruh, Michael V. Rocco, Glenn M. Chertow> ;Clinical Journal of the American Society of Nephrology. 2012 May 1
• 23 citations
  Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis
  Maria-Grazia Ascenzi, Vivian P Liao, Brittany M Lee, Fabrizio Billi, Hua Zhou, Robert Lindsay, Felicia Cosman, Jeri W. Nieves, John P. Bilezikian, David W. Dempster> ;Journal of Bone and Mineral Research. 2012 Mar 1
• Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors.
  Roux C, Goldstein JL, Zhou X, Klemes A, Lindsay R> ;Osteoporos Int. 2012-01-01
• The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.
  Rocco MV, Lockridge RS, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin ...> ;Kidney Int.. 2011-11-01
• 14 citations
  Preventing osteoporosis with a tissue selective estrogen complex (TSEC) containing bazedoxifene/conjugated estrogens (BZA/CE).
  R. Lindsay> ;Osteoporosis International. 2011 Feb 1
• 56 citations
  Baseline Physical Performance, Health, and Functioning of Participants in the Frequent Hemodialysis Network (FHN) Trial
  George A. Kaysen, Brett Larive, Patricia Painter, Alexander Craig, Robert M. Lindsay, Michael V. Rocco, John T. Daugirdas, Gerald Schulman, Glenn M. Chertow> ;American Journal of Kidney Diseases. 2011 Jan 1
• Join now to see all

Other

• Short daily hemodialysis 
  Lindsay RM, Pierratos A, Nesrallah GE
  http://www.uptodate.com/contents/short-daily-hemodialysis
  UpToDate, Wolters Kluwer Health - 2013-04-12